Ras oncogene induces β‐galactoside α2,6‐sialyltransferase (ST6Gal I) via a RalGEF‐mediated signal to its housekeeping promoter
- 24 August 2004
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 271 (18), 3623-3634
- https://doi.org/10.1111/j.1432-1033.2004.04284.x
Abstract
Several oncogenic proteins are known to influence cellular glycosylation. In particular, transfection of codon 12 point mutated H-Ras increases CMP-Neu5Ac: Galbeta1,4GlcNAc alpha2,6-sialyltransferase I (ST6Gal I) activity in rodent fibroblasts. Given that Ras mediates its effects through at least three secondary effector pathways (Raf, RalGEFs and PI3K) and that transcriptional control of mouse ST6Gal I is achieved by the selective use of multiple promoters, we attempted to identify which of these parameters are involved in linking the Ras signal to ST6Gal I gene transcription in mouse fibroblasts. Transformation by human K-Ras or H-Ras (S12 and V12 point mutations, respectively) results in a 10-fold increase in ST6Gal I mRNA, but no alteration in the expression of related sialyltransferases. Using an inducible H-RasV12 expression system, a direct causal link between activated H-Ras expression and elevated ST6Gal I mRNA was demonstrated. The accumulation of the ST6Gal I transcript in response to activated Ras was accompanied by an increase of alpha2,6-sialyltransferase activity and of Neu5Acalpha2,6Gal at the cell surface. Results obtained with H-RasV12 partial loss of function mutants H-RasV12S35 (Raf signal only), H-RasV12C40 (PI3-kinase signal only) and H-RasV12G37 (RalGEFs signal only) suggest that the H-Ras induction of the mouse ST6Gal I gene (Siat1) transcription is primarily routed through RalGEFs. 5'-Rapid amplification of cDNA ends analysis demonstrated that the increase in ST6Gal I mRNA upon H-RasV12 or K-RasS12 transfection is mediated by the Siat1 housekeeping promoter P3-associated 5' untranslated exons.Keywords
This publication has 45 references indexed in Scilit:
- Comparison of the Enzymatic Properties of Mouse -Galactoside 2,6-Sialyltransferases, ST6Gal I and IIThe Journal of Biochemistry, 2003
- Distinct requirements for Ras oncogenesis in human versus mouse cellsGenes & Development, 2002
- Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulationOncogene, 2002
- Altered mRNA Expression of Sialyltransferase in Squamous Cell Carcinomas of the CervixGynecologic Oncology, 2001
- β-galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity withsambucus nigra agglutininInternational Journal of Cancer, 2000
- Differential Expression of α2,6-Sialyltransferase in Colon Tumors Recognized by a Monoclonal AntibodyHybridoma, 1998
- Transcription of the β-galactoside α2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter†Glycobiology, 1996
- p21ras: An oncoprotein functioning in growth factor-induced signal transductionEuropean Journal Of Cancer, 1995
- High alpha-2,6-sialylation of N-acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potentialGlycobiology, 1995
- The c-Ha-ras oncogene induces increased expression of β-galactoside α-2,6-sialyltransferase in rat fibroblast (FR3T3) cellsGlycobiology, 1992